Priority Healthcare Distribution Inc.

Lake Mary, FL Doing business as Curascript SD Specialty Distribution Part of Express Scripts Inc.

UEI
JCVFNPM8CNS3
CAGE
3CCQ4
Primary NAICS
456110 Pharmacies and Drug Retailers
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Express Scripts Inc., ranks:

and 4 more

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
255 Technology Park, Lake Mary, FL 32746, USA
Founded
1994
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
51 Wholesale Trade – Nondurable Goods
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $97,228
FY2026 $1,498,693
FY2025 $1,990,148
FY2024 $4,593,783
FY2023 $6,210,207

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Justice $1,389,353
2 Department of Veterans Affairs $206,567

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, supplies specialty pharmaceutical products to federal healthcare agencies and correctional facilities as a prime contractor on full-and-open purchase orders with no SBA set-aside posture. The vendor is a for-profit child entity of Express Scripts Inc., headquartered in Lake Mary, Florida, and competes across full competition without set-aside reserve, with rare exceptions where individual awards carry Total Small Business designations.

The vendor's federal footprint centers on distributing high-cost specialty medications to the Department of Veterans Affairs, the Bureau of Prisons, and Department of Health and Human Services facilities. Curascript specializes in rare-disease and complex-condition pharmaceuticals including treprostinil (Tyvaso), selexipag (Uptravi), abaloparatide (Tymlos), ambrisentan (Letairis), riociguat (Adempas), macitentan (Opsumit), voxelotor (Oxbryta), and photodynamic therapy agents such as Photofrin. Representative awards include a $718.6 million sole-source purchase order from Veterans Integrated Service Network 22 for Tymlos in January 2024; a $1.3 million sole-source order for Tymlos from the same network in September 2023; a $351.2 thousand order from Veterans Integrated Service Network 7 for Charleston Consolidated Mail-Out Pharmacy in November 2023; recurring monthly orders from Federal Correctional Institution Fort Worth and Federal Correctional Complex Butner ranging from $11 thousand to $180 thousand for inmate medication supply; and routine replenishment orders from Federal Medical Center Devens for Uptravi and related cardiovascular agents. The vendor operates across 40 distinct federal agencies, though customer concentration is high among VA networks and Bureau of Prisons facilities. Approximately 28% of awards are distributed across the top five customer agencies: Veterans Integrated Service Network 19 (65 awards, $820 thousand), Veterans Integrated Service Network 12 (47 awards, $5.7 million), Federal Correctional Complex Butner (42 awards, $1.2 million), Federal Correctional Institution Fort Worth (40 awards, $3 million), and Department of Health and Human Services Indian Health Service (92 awards, $913 thousand). By potential value, Veterans Integrated Service Network 22 dominates with 32 awards worth $12 million combined, reflecting multiple sole-source high-dollar pharmaceutical buys. The Department of the Army Medical Command ranks second with 30 awards totaling $6.1 million.

Recent activity shows steady engagement with a mixed trajectory: ten awards in 2022, 42 in 2023, 34 in 2024, 42 in 2025, and 28 through early October 2026 in the current year. The vendor sits on five primary parent vehicles: Blanket Purchase Agreement HHSI242201100044B (32 task orders, $139 thousand combined potential value), Blanket Purchase Agreement HHSI244201300046B (8 task orders, $54 thousand), Blanket Purchase Agreement HHSI244201200048B (7 task orders, $33 thousand), Blanket Purchase Agreement HHSI244201000062B (6 task orders), and Federal Supply Schedule V797P5435X (6 task orders). The recompete cliff shows minimal near-term exposure: only one award with ultimate completion in the next twenty-four months carries $31 thousand in potential value, indicating stable contract incumbency across a mature portfolio. The vendor's primary NAICS concentration splits between Pharmaceutical Preparation Manufacturing (371 awards), Pharmacies and Drug Stores (193 awards), and Drugs and Druggists' Sundries Merchant Wholesalers (46 awards), with PSC coding reflecting 841 awards under Drugs and Biologicals and 106 under Medical and Surgical Instruments, Equipment, and Supplies. Combined potential value across the 1,012 awards totals $41.9 million, with $36.2 million obligated (86% execution rate).

SBA capabilities narrative

CuraScript SD supplies biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products for office or clinic administration to a wide range of medical providers.

Quick answers

Is Priority Healthcare Distribution Inc. registered in SAM.gov?

Yes. Priority Healthcare Distribution Inc.'s SAM.gov registration is active through July 10, 2027.

How much has Priority Healthcare Distribution Inc. received in federal contracts?

Federal contracts obligated $1,990,148 to Priority Healthcare Distribution Inc. in fiscal year 2025 and $14,390,059 in fiscal years 2023 through 2027.

How does Priority Healthcare Distribution Inc. rank among federal contractors?

Priority Healthcare Distribution Inc. ranked #4 in NAICS 456, #6 in NAICS 4242 and #27 in NAICS 424 in FY2025.

What is Priority Healthcare Distribution Inc.'s most recent federal award?

Priority Healthcare Distribution Inc.'s most recent federal contract award is National drug code: 66215-0608-06 trade name: uptravi 1000MCG 60 count bottle VA class: cardiovascular agents, other EO… (15B20527P00000017), from Federal Medical Center Devens (BOP), on October 1, 2026.

On GovTribe

See Priority Healthcare Distribution Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors